STAT
OCTOBER 6, 2023
If the Covid-19 pandemic has shown us one thing, it is how little we really know about how the human immune system works. Despite the remarkable success in development of vaccines to prevent severe disease from SARS-CoV-2, it remains unclear how SARS-CoV-2, a newly emerging virus, causes such a broad spectrum of disease , ranging from asymptomatic and mild cases to severe disease and death.
PharmaVoice
OCTOBER 6, 2023
Trade shows and events focused on the industry’s hot-button topics, technologies and trends.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
OCTOBER 6, 2023
In a fall in which new tools to fight old diseases — updated Covid-19 vaccines, new products to protect older adults and babies from RSV — have been introduced with fanfare but rolled out in a particularly rocky manner, frustration may be about to go next level. Parents of young babies are anxiously waiting to find out how and where they’ll be able to get their children shots of Sanofi’s new monoclonal antibody that protects against RSV, or respiratory syncytial virus
PharmaVoice
OCTOBER 6, 2023
In a crowded biotech market, here’s how your company can stand out to investors.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
OCTOBER 6, 2023
In a setback for Novo Nordisk, a U.S. judge dismissed its lawsuit accusing a compound pharmacy of selling versions of its Wegovy and Ozempic medicines, which are widely prescribed for weight loss and have become franchise products for the drug company. The decision, which was conveyed in a one-page filing in the court docket, comes after Novo Nordisk filed lawsuits last July against Brooksville Pharmaceuticals and three other compound pharmacies for allegedly violating laws in different states.
BioPharma Dive
OCTOBER 6, 2023
The funding, which is part of ACT for ALS, will support expanded access studies of drugs developed by Prilenia Therapeutics, Clene Nanomedicine and Rapa Therapeutics.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
The Pharmacist
OCTOBER 6, 2023
Women who smoke during pregnancy are 2.6 times more likely to give birth prematurely than non-smokers, almost double previous estimates. In a new study, researchers at the University of Cambridge showed that smoking during pregnancy is linked to premature birth and low birth weights. Babies born to mothers who smoked throughout their pregnancy were four […] The post Risk of premature birth from smoking while pregnant more than double previous estimates appeared first on The Pharmacist.
STAT
OCTOBER 6, 2023
Within the linings of our guts, immune cells patrol like sentries on a castle wall. These cells, called intraepithelial T lymphocytes, are constantly probing the cells of the gut barrier for signs of disease, killing any cells that appear suspect due to infections or cancer mutations. A new paper published in Science Immunology on Friday suggests that a subtype of T cells called gamma-delta T cells may be key to that process — and that a protein known as TCF-1 is central to controlling th
Digital Pharmacist
OCTOBER 6, 2023
ConclusionI n July 2023, Florida passed the Prescription Drug Reform Act (Chapter 2023-29). Now, what is this act? The Prescription Drug Reform Act aims to regulate pharmacy benefit managers (PBMs) and pharmaceutical manufacturers in the state. The primary focus of this act is to bring transparency, accountability, and fairness to the outpatient pharmaceutical system in Florida, especially in relation to PBMs.
STAT
OCTOBER 6, 2023
Earlier this year, Food and Drug Administration Commissioner Robert M. Califf proposed something radical: that private health care insurance companies (payers) should participate in clinical research on FDA-approved drugs. This challenges the prevailing convention that only drug developers conduct such studies — and it’s an idea worth considering.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmafile
OCTOBER 6, 2023
Sanofi has shared new data for the long-term efficacy of Nexviazyme (avalglucosidease alfa) for the treatment of Pompe disease at the 28th Annual Congress of the World Muscle Society (WMS) in Charleston, South Carolina, US. Nexviazyme is approved in the US and elsewhere as a monotherqapy for the treatment of late-onset Pompe disease, and is […] The post Sanofi shares new data for long-term efficacy of Nexviazyme for Pompe disease treatment appeared first on Pharmafile.
STAT
OCTOBER 6, 2023
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still taking shape, but we expect to hang with our shortest person, who returns for a quick break from an institution of higher learning, catch up on sundry chores and, if possible, hold another listening party.
The Pharmacist
OCTOBER 6, 2023
The King’s Fund and the Nuffield Trust were commissioned by Community Pharmacy England (CPE) to develop a vision for community pharmacy that would support CPE in its leadership role, underpin a strategy for the sector and suggest how the vision might be implemented. That vision was published in September 2023 after almost a year of […] The post How ICS leaders can approach community pharmacy appeared first on The Pharmacist.
STAT
OCTOBER 6, 2023
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
Pharma Times
OCTOBER 6, 2023
The study used data from 50,000 people in the UK Biobank - News - PharmaTimes
STAT
OCTOBER 6, 2023
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hi! Today, we discuss why an advisory committee was not thrilled with Amgen’s data for Lumakras, and Neurocrine Biosciences has a potential blockbuster up its sleeve. Oh, and we’ll be off for Indigenous Peoples’ Day next week and will be back in your inbox Tuesday!
Pharma Times
OCTOBER 6, 2023
NPIP will transform medical research and provide better outcomes for patients - News - PharmaTimes
European Pharmaceutical Review
OCTOBER 6, 2023
Positive interim results from Moderna’s Phase I/II trial of mRNA-1083 , an investigational vaccine designed to immunise against both influenza and COVID-19, have been released. There are several benefits of the combination vaccine as a preventative measure against these respiratory conditions, according to the pharmaceutical company. For example: higher patient compliance, easier administration and greater convenience.
Express Pharma
OCTOBER 6, 2023
Biocon has signed a partnership agreement with Juno Pharmaceuticals, a specialty pharmaceutical company in Canada, for the commercialisation of its vertically integrated, complex formulation, Liraglutide, a drug-device combination for the treatment and management of Type 2 diabetes and obesity. Under the terms of this agreement, Biocon will be responsible for obtaining regulatory approval for Liraglutide, and thereafter, for the manufacture and supply of the product in the Canadian market Juno s
Pharmaceutical Commerce
OCTOBER 6, 2023
Sr. Director of Community Engagement for Pharmaceuticals at GS1 US explains what the implementation guidelines are meant to accomplish.
European Pharmaceutical Review
OCTOBER 6, 2023
The Indian Pharmacopoeia Commission (IPC) is now a member the Pharmacopoeial Discussion Group (PDG). As the Indian pharmaceutical industry is “a major manufacturer of the world’s medicines,” Jaap Venema, PhD, Executive Vice President and Chief Science Officer for USP declared, inclusion of the IPC in the discussion group is a “milestone” in expanding recognition of harmonised pharmacopoeial standards, Cathie Vielle, Secretary to the European Pharmacopoeia Commission added.
Outsourcing Pharma
OCTOBER 6, 2023
EDETEK and Pfizer are in collaboration to speed access to clinical data, promote interoperability and enable data visualization to drive faster decision-making capabilities in clinical operations.
Pharmaceutical Commerce
OCTOBER 6, 2023
Conference hosts roundtable chats, with topics ranging from data-driven decision making to cold chain logistics.
Pharmaceutical Technology
OCTOBER 6, 2023
Ocular Therapeutix has confirmed the launch of a trial of an intravitreal eye implant intended to combat macular degeneration.
Drug Patent Watch
OCTOBER 6, 2023
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com The post New tentative approval for Mylan Gmbh drug trastuzumab-dkst appeared first on DrugPatentWatch - Make Better Decisions.
Drug Channels
OCTOBER 6, 2023
Today’s guest post comes from Michael Carr, Group Vice President, CoAssist Pharmacy at AssistRx. Michael discusses the challenges that patients and healthcare providers face during the prescription intake and enrollment process. He outlines four key features of solutions that improve digital intake. To learn about AssistRx’s digital intake technologies, download their case study: Digital Intake for More Meaningful Patient and HCP Interactions.
The Pharmacist
OCTOBER 6, 2023
Prime Minister Rishi Sunak focused on preventative healthcare in his speech at the Conservative Party Conference this week, announcing his intention to raise the smoking age by one year every year, and to bring forward measures to restrict the availability of vapes to children. Chair of the Health and Social Care Committee (HSCC) Steve Brine, […] The post Moves to cut smoking ‘welcome’ but careful approach needed on vaping appeared first on The Pharmacist.
World Pharma News
OCTOBER 6, 2023
Every year, over 15,500 Australians are diagnosed with bowel cancer, and it is the second leading cause of cancer deaths in the country. Over 1,700 (one in ten) of those diagnosed are young Australians aged under 50, and this incidence is increasing. There is an urgent need to discover more effective treatments and improve bowel cancer screening, particularly for early-onset bowel cancer (those aged 25-49 years).
PharmExec
OCTOBER 6, 2023
Lofaso discusses strategies that biotech companies can take once its time to make the big push.
pharmaphorum
OCTOBER 6, 2023
What AI really means for biology and the pharmaceutical industry Mike.
PharmExec
OCTOBER 6, 2023
Kalinovich previously worked at Wabtec as a corporate vice president.
Drug Patent Watch
OCTOBER 6, 2023
Annual Drug Patent Expirations for TIVICAY Tivicay is a drug marketed by Viiv Hlthcare and is included in two NDAs. It is available from three suppliers. There are two patents… The post New patent for Viiv Hlthcare drug TIVICAY appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
OCTOBER 6, 2023
UK launches total-body PET drive to support drug discovery Phil.
BioPharma Dive
OCTOBER 6, 2023
Regulators’ holdup of the deal had stoked investor fears of greater scrutiny on M&A. In the end, Amgen agreed to requirements meant to guard against product “bundling.
pharmaphorum
OCTOBER 6, 2023
Empowering health through innovation: Smartwatches as diagnostic aids Mike.
Expert insights. Personalized for you.
335 
Let's personalize your content